Physician profile
Farah Salahuddin
NPI 1437206893
$1,192.33
in general payments reported to CMS, 2019-2025
10 companies · $481 in 2025
The $481 reported for 2025 was less than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $125 · 2020: $109 · 2021: $205 · 2022: $132 · 2023: $104 · 2024: $36.32 · 2025: $481.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $461 · Food and Beverage: $161.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $461.03 |
| Food and Beverage | $160.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $477.21 | 2024-2025 | Minimed 780g |
| Novo Nordisk INC | $134.93 | 2021 | |
| Abbott Laboratories | $128.29 | 2021-2024 | Freestyle Libre 3 |
| Ucb, INC. | $124.87 | 2019 | |
| Pfizer INC. | $96.28 | 2020-2021 | |
| Lilly USA, LLC | $86.43 | 2023 | Mounjaro |
| Dexcom, INC. | $78.24 | 2022 | |
| Radius Health, INC. | $24.47 | 2020 | |
| Genzyme Corporation | $21.58 | 2020 | |
| Sequel Med Tech, LLC | $20.03 | 2025 | Twiist |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Farah Salahuddin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.